C. Tschanz, W.W. Stargel, and J.A. Thomas, Interactions between Drugs and Nutrients. I. Appleton, A. Tomlinson, and D.A. Willoughby, Induction of Cyclo-Oxygenase and Nitric Oxide Synthase in Inflammation. J.A. Farmer and A.M. Gotto, Jr., Current and Future Therapeutic Approaches to Hyperlipidemia. J.F. Borel, G. Baumann, I. Chapman, P. Donatsch, A. Fahr, E.A. Mueller, and J.-M. Vigouret, In Vivo Pharmacological Effects of Ciclosporin and Some Analogues. I.J. Okazaki and J. Moss, Mono-ADP-ribosylation: A Reversible Posttranslational Modification of Proteins. S.R. Denmeade and J.T. Isaacs, Activation of Programmed (Apoptotic) Cell Death for the Treatment of Prostate Cancer. H.N. Hodis, Reversal of Atherosclerosis with Therapy: Update of Coronary Angiographic Trials. L.A. Loeb, Unnatural Nucleotide Sequences in Biopharmaceutics. S.P. Aiken, R. Zaczek, and B.S. Brown, Pharmacology of the Neurotransmitter Release Enhancer Linopirdine (DuP 996), and Insights into Its Mechanism of Action. Chapter References. Subject Index. Contents of Previous Volumes.
